Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 13-Aug-24 4:15 PM View:  | Xeris Biopharma Holdings, I... (XERS) | 12-Aug-24 | Market Purchase | 4,515 | $2.25 | $10,147.00 | 3% 133.84K to 138.36K | 9% |
| 12-Aug-24 6:28 PM View: | Xeris Biopharma Holdings, I... (XERS) | 09-Aug-24 | Market Purchase | 4,285 | $2.37 | $10,134.00 | 3% 129.56K to 133.84K | 3% |
| 18-Jun-24 8:17 PM View: | Anaptysbio, Inc (ANAB) | 15-Jun-24 | Option Exercise | 3,900 | -- | -- | 100% 0 to 3.9K | |
| 05-Jun-24 4:19 PM View: | Xeris Biopharma Holdings, I... (XERS) | 05-Jun-24 | Grant | 50,000 | -- | -- | 63% 79.56K to 129.56K | |
| 10-May-24 4:04 PM View: | Xeris Biopharma Holdings, I... (XERS) | 10-May-24 | Private Purchase | 5,400 | $1.91 | $10,314.00 | 7% 74.16K to 79.56K | |
| 25-Mar-24 7:10 PM View: | Design Therapeutics, Inc. (DSGN) | 25-Mar-24 | Purchase | 17,809 | $3.74 | $66,605.70 | 36% 48.99K to 66.8K | |
| 25-Mar-24 7:10 PM View: | Design Therapeutics, Inc. (DSGN) | 22-Mar-24 | Private Purchase | 9,156 | $3.62 | $33,132.80 | 23% 39.83K to 48.99K | |
| 14-Mar-24 9:03 PM View: | Xeris Biopharma Holdings, I... (XERS) | 14-Mar-24 | Private Purchase | 4,500 | $2.16 | $9,720.00 | 6% 69.66K to 74.16K | |
| 17-Nov-23 6:35 PM View: | Xeris Biopharma Holdings, I... (XERS) | 16-Nov-23 | Private Purchase | 6,500 | $1.51 | $9,815.00 | 10% 63.16K to 69.66K | |
| 16-Jun-23 4:09 PM View: | Poseida Therapeutics, Inc. (PSTX) | 15-Jun-23 | Grant | 19,650 | -- | -- | 100% 19.65K to 39.3K | |
| 07-Jun-23 4:55 PM View: | Xeris Biopharma Holdings, I... (XERS) | 07-Jun-23 | Grant | 42,500 | -- | -- | 206% 20.66K to 63.16K | |
| 16-Jun-22 8:56 PM View: | Poseida Therapeutics, Inc. (PSTX) | 16-Jun-22 | Grant | 19,650 | -- | -- | 100% 0 to 19.65K | |
| 09-Jun-22 5:13 PM View: | Xeris Biopharma Holdings, I... (XERS) | 08-Jun-22 | Grant | 15,000 | -- | -- | 265% 5.66K to 20.66K | |
| 05-Oct-21 5:37 PM View: | Xeris Pharmaceuticals Inc (XERS) | 05-Oct-21 | Disposition | 5,659 | -- | -- | (100%) 5.66K to 0 | |
| 05-Oct-21 7:41 PM View: | Xeris Biopharma Holdings, I... (XERS) | 05-Oct-21 | Grant | 5,659 | -- | -- | 100% 0 to 5.66K | |
| 19-Mar-21 5:33 PM View: | Neos Therapeutics, Inc. (NEOS) | 19-Mar-21 | Disposition | 23,453 | -- | -- | (100%) 23.45K to 0 | |
| 11-Jun-20 8:24 PM View: | Neos Therapeutics, Inc. (NEOS) | 10-Jun-20 | Grant | 23,453 | -- | -- | 100% 0 to 23.45K | |
| 06-May-15 6:05 PM View: | Auspex Pharmaceuticals, Inc. (ASPX) | 05-May-15 | Disposition (change in control) | 144,444 | -- | -- | (100%) 144.44K to 0 | |
| 13-Sep-13 7:19 PM View: | Trius Therapeutics Inc (TSRX) | 11-Sep-13 | Disposition | 107,639 | -- | -- | (100%) 107.64K to 0 | |
| 25-Jun-12 1:07 PM View: | Trius Therapeutics Inc (TSRX) | 22-Jun-12 | Market Sale (Planned) | 1,800 | $6.00 | $10,800.00 | (2%) 109.44K to 107.64K | (128%) |
| 28-Mar-12 3:50 PM View: | Trius Therapeutics Inc (TSRX) | 27-Mar-12 | Option Exercise | 5,000 | $1.29 | $6,450.00 | 5% 104.44K to 109.44K | |
| 02-Mar-12 2:38 PM View: | Trius Therapeutics Inc (TSRX) | 01-Mar-12 | Market Sale (Planned) | 500 | $5.04 | $2,520.00 | (< 1%) 104.94K to 104.44K | (171%) |
| 06-Feb-12 1:23 PM View: | Trius Therapeutics Inc (TSRX) | 02-Feb-12 | Market Sale (Planned) | 500 | $5.63 | $2,815.00 | (< 1%) 105.44K to 104.94K | (143%) |
| 04-Jan-12 4:08 PM View: | Trius Therapeutics Inc (TSRX) | 03-Jan-12 | Market Sale (Planned) | 700 | $7.28 | $5,096.00 | (< 1%) 106.14K to 105.44K | (88%) |
| 02-Dec-11 2:30 PM View: | Trius Therapeutics Inc (TSRX) | 01-Dec-11 | Market Sale (Planned) | 700 | $7.50 | $5,250.00 | (< 1%) 106.84K to 106.14K | (82%) |
| 08-Nov-11 1:18 PM View: | Trius Therapeutics Inc (TSRX) | 07-Nov-11 | Market Sale (Planned) | 100 | $7.00 | $700.00 | (< 1%) 106.94K to 106.84K | (95%) |
| 01-Nov-11 4:37 PM View: | Trius Therapeutics Inc (TSRX) | 01-Nov-11 | Market Sale (Planned) | 600 | $6.75 | $4,050.00 | (< 1%) 107.54K to 106.94K | (103%) |
| 27-Oct-11 1:56 PM View: | Trius Therapeutics Inc (TSRX) | 26-Oct-11 | Market Sale (Planned) | 200 | $7.00 | $1,400.00 | (< 1%) 107.74K to 107.54K | (95%) |
| 04-Oct-11 1:16 PM View: | Trius Therapeutics Inc (TSRX) | 03-Oct-11 | Market Sale (Planned) | 600 | $6.33 | $3,798.00 | (< 1%) 108.34K to 107.74K | (116%) |
| 02-Sep-11 7:37 PM View: | Trius Therapeutics Inc (TSRX) | 01-Sep-11 | Market Sale (Planned) | 600 | $6.60 | $3,960.00 | (< 1%) 108.94K to 108.34K | (107%) |
| 02-Aug-11 1:16 PM View: | Trius Therapeutics Inc (TSRX) | 01-Aug-11 | Market Sale (Planned) | 1,200 | $8.85 | $10,622.40 | (1%) 110.14K to 108.94K | (54%) |
| 21-Jul-11 4:45 PM View: | Trius Therapeutics Inc (TSRX) | 20-Jul-11 | Market Sale (Planned) | 100 | $8.00 | $800.00 | (< 1%) 110.24K to 110.14K | (71%) |
| 05-Jul-11 2:37 PM View: | Trius Therapeutics Inc (TSRX) | 01-Jul-11 | Market Sale (Planned) | 700 | $7.93 | $5,550.30 | (< 1%) 110.94K to 110.24K | (72%) |
| 01-Jun-11 9:13 PM View: | Trius Therapeutics Inc (TSRX) | 01-Jun-11 | Market Sale (Planned) | 800 | $7.90 | $6,323.00 | (< 1%) 111.74K to 110.94K | (73%) |
| 18-May-11 1:05 PM View: | Trius Therapeutics Inc (TSRX) | 16-May-11 | Market Sale (Planned) | 400 | $8.00 | $3,200.00 | (< 1%) 112.14K to 111.74K | (71%) |
| 09-May-11 1:51 PM View: | Trius Therapeutics Inc (TSRX) | 05-May-11 | Market Sale (Planned) | 200 | $7.00 | $1,400.00 | (< 1%) 112.34K to 112.14K | (95%) |
| 03-May-11 4:07 PM View: | Trius Therapeutics Inc (TSRX) | 03-May-11 | Market Sale (Planned) | 200 | $6.00 | $1,200.00 | (< 1%) 112.54K to 112.34K | (128%) |
| 03-May-11 4:07 PM View: | Trius Therapeutics Inc (TSRX) | 02-May-11 | Market Sale (Planned) | 500 | $5.62 | $2,810.00 | (< 1%) 113.04K to 112.54K | (143%) |
| 04-Apr-11 2:07 PM View: | Trius Therapeutics Inc (TSRX) | 01-Apr-11 | Market Sale (Planned) | 500 | $5.66 | $2,830.00 | (< 1%) 113.54K to 113.04K | (141%) |
| 03-Mar-11 6:49 AM View: | Trius Therapeutics Inc (TSRX) | 01-Mar-11 | Market Sale (Planned) | 1,400 | $7.04 | $9,856.00 | (1%) 114.94K to 113.54K | (94%) |